Fellow Eye Comparisons for 7-Year Outcomes in Ranibizumab-Treated AMD Subjects from ANCHOR, MARINA, and HORIZON (SEVEN-UP Study)

Ophthalmology

Volumn 123, Issue 6, 2016, Pages 1269-1277

  Bhisitkul, Robert B ^a   Desai, Shilpa J ^a   Boyer, David S ^b   Sadda, Srinivas R ^c   Zhang, Kang ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Retina Vitreous Assoct   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB; VASCULOTROPIN ANTIBODY; ANGIOGENESIS INHIBITOR; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

AGE RELATED MACULAR DEGENERATION; AGED; ARTICLE; CONTROLLED STUDY; DATA BASE; FEMALE; HUMAN; MACULAR DEGENERATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; SECONDARY ANALYSIS; SUBRETINAL NEOVASCULARIZATION; VISION; VISUAL ACUITY; ANTAGONISTS AND INHIBITORS; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE COURSE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; INTRAVITREAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME; WET MACULAR DEGENERATION;

AGED; ANGIOGENESIS INHIBITORS; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INTRAVITREAL INJECTIONS; MALE; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RANIBIZUMAB; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; WET MACULAR DEGENERATION;

EID: 84961219316     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2016.01.033     Document Type: Article

References (22)

1. D.M. Brown, P.K. Kaiser, M. Michels, and et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration N Engl J Med 355 2006 1432 1444
2. D.M. Brown, M. Michels, P.K. Kaiser, and et al. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study Ophthalmology 116 2009 57 65
3. P.J. Rosenfeld, D.M. Brown, J.S. Heier, and et al. Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 2006 1419 1431
4. M.A. Singer, C.C. Awh, S. Sadda, and et al. HORIZON: an open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degeneration Ophthalmology 119 2012 1175 1183
5. R.B. Bhisitkul, T.S. Mendes, S. Rofagha, and et al. Macular atrophy progression and 7-year vision outcomes in subjects from the ANCHOR, MARINA, and HORIZON studies: the SEVEN-UP study Am J Ophthalmol 159 2015 915 924
6. N. Lois, V. McBain, E. Abdelkader, and et al. Retinal pigment epithelial atrophy in patients with exudative age-related macular degeneration undergoing anti-vascular endothelial growth factor therapy Retina 33 2013 13 22
7. U. Chakravarthy, S.P. Harding, C.A. Rogers, et al. IVAN study investigators Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial Lancet 382 2013 1258 1267
8. J.E. Grunwald, E. Daniel, J. Huang, et al. CATT Research Group Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials Ophthalmology 121 2014 150 161
9. J.E. Grunwald, M. Pistilli, G.S. Ying, et al. CATT Research Group Growth of geographic atrophy in the comparison of age-related macular degeneration treatments trials Ophthalmology 122 2015 809 816
10. S. Rofagha, R.B. Bhisitkul, D.S. Boyer, and et al. Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP) Ophthalmology 120 2013 2292 2299
11. D.S. Boyer, A.N. Antoszyk, C. Awh, and et al. Subgroups analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration Ophthalmology 114 2007 246 252
12. Macular Photocoagulation Study Group Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration Arch Ophthalmol 115 1997 741 747
13. D.J. Pieramici, and S.B. Bressler Age-related macular degeneration and risk factors for the development of choroidal neovascularization in the second fellow eye Curr Opin Ophthalmol 9 1998 38 46
14. I.A. Barbazetto, N. Saroj, H. Shapiro, and et al. Incidence of new choroidal neovascularization in fellow eyes of patients treated in the MARINA and ANCHOR trials Am J Ophthalmol 149 2010 939 946
15. M.G. Maguire, E. Daniel, A.R. Shah, et al. CATT Research Group Incidence of choroidal neovascularization in the fellow eye in the comparison of age-related macular degeneration treatments trials Ophthalmology 120 2013 2035 2041
16. N. Kumar, S. Mrejen, A.T. Fung, and et al. Retinal pigment epithelial cell loss assessed by fundus autofluorescence imaging in neovascular age-related macular degeneration Ophthalmology 120 2013 334 341
17. P.J. Rosenfeld, H. Shapiro, L. Tuomi, and et al. Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials Ophthalmology 118 2011 523 530
18. M. Saint-Geniez, T. Kurihara, E. Sekiyama, and et al. An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris Proc Natl Acad Sci U S A 106 2009 18751 18756
19. K.M. Ford, M. Saint-Geniez, T. Walshe, and et al. Expression and role of VEGF in the adult retinal pigment epithelium Invest Ophthalmol Vis Sci 52 2011 9478 9487
20. T. Kurihara, P.D. Westenskow, S. Bravo, and et al. Targeted deletion of Vegfa in adult mice induces vision loss J Clin Invest 122 2012 4213 4217
21. M.C. Peden, I.J. Suñer, M.E. Hammer, and W.S. Grizzard Long-term outcomes in eyes receiving fixed-interval dosing of anti-vascular endothelial growth factor agents for wet age-related macular degeneration Ophthalmology 122 2015 803 808
22. J.J. Arnold, A. Campain, D. Barthelmes, and et al. Two-year outcomes of "treat and extend" intravitreal therapy for neovascular age-related macular degeneration Ophthalmology 122 2015 1212 1219